% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Neumeyer:136773,
author = {S. M. Neumeyer$^*$ and B. L. Banbury and V. Arndt$^*$ and
S. I. Berndt and S. Bezieau and S. A. Bien and D. D.
Buchanan and K. Butterbach$^*$ and B. J. Caan and P. T.
Campbell and G. Casey and A. T. Chan and S. J. Chanock and
J. Y. Dai and S. Gallinger and E. L. Giovannucci and G. G.
Giles and W. M. Grady and J. Hampe and M. Hoffmeister$^*$
and J. L. Hopper and L. Hsu and M. A. Jenkins and A. Joshi
and S. C. Larsson and L. Le Marchand and A. Lindblom and V.
Moreno and M. Lemire and L. Li and Y. Lin and K. Offit and
P. A. Newcomb and P. D. Pharaoh and J. D. Potter and L. Qi
and G. Rennert and C. Schafmayer and R. E. Schoen and M. L.
Slattery and M. Song and C. M. Ulrich and A. K. Win and E.
White and A. Wolk and M. O. Woods and A. H. Wu and S. B.
Gruber and H. Brenner$^*$ and U. Peters and J.
Chang-Claude$^*$},
title = {{M}endelian randomisation study of age at menarche and age
at menopause and the risk of colorectal cancer.},
journal = {British journal of cancer},
volume = {118},
number = {12},
issn = {1532-1827},
address = {Edinburgh},
publisher = {Nature Publ. Group},
reportid = {DKFZ-2018-01211},
pages = {1639 - 1647},
year = {2018},
abstract = {Substantial evidence supports an association between use of
menopausal hormone therapy and decreased colorectal cancer
(CRC) risk, indicating a role of exogenous sex hormones in
CRC development. However, findings on endogenous oestrogen
exposure and CRC are inconsistent.We used a Mendelian
randomisation approach to test for a causal effect of age at
menarche and age at menopause as surrogates for endogenous
oestrogen exposure on CRC risk. Weighted genetic risk scores
based on 358 single-nucleotide polymorphisms associated with
age at menarche and 51 single-nucleotide polymorphisms
associated with age at menopause were used to estimate the
association with CRC risk using logistic regression in
12,944 women diagnosed with CRC and 10,741 women without CRC
from three consortia. Sensitivity analyses were conducted to
address pleiotropy and possible confounding by body mass
index.Genetic risk scores for age at menarche (odds ratio
per year 0.98, $95\%$ confidence interval: 0.95-1.02) and
age at menopause (odds ratio 0.98, $95\%$ confidence
interval: 0.94-1.01) were not significantly associated with
CRC risk. The sensitivity analyses yielded similar
results.Our study does not support a causal relationship
between genetic risk scores for age at menarche and age at
menopause and CRC risk.},
cin = {C020 / C070 / G110 / L101},
ddc = {610},
cid = {I:(DE-He78)C020-20160331 / I:(DE-He78)C070-20160331 /
I:(DE-He78)G110-20160331 / I:(DE-He78)L101-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29795306},
pmc = {pmc:PMC6008474},
doi = {10.1038/s41416-018-0108-8},
url = {https://inrepo02.dkfz.de/record/136773},
}